• 單元主視覺

December 2018 Sunny’s co-development ANDA of Cyanocobalamin Injection has been approved by US FDA

December 2018 Sunny’s co-development ANDA of Cyanocobalamin Injection has been approved by US FDA
2018/12/19
Sunny Pharmtech Inc. announced that its co-development ANDA(“Abbreviated New Drug Application”) of Cyanocobalamin Injection has been officially approved by US FDA on 2018/12/19.  Cyanocobalamin Injection is indicated for vitamin B12 deficiencies.
According to IMS data, the total sales of Cyanocobalamin Injection in the US were approximately US $80 million for the 12 months ended December 2017.  Sunny is now preparing for launch accordingly and will commercialize the product through Sunny’s business partner in the US market.
 
Home/News/News/December 2018 Sunny’s co-development ANDA of Cyanocobalamin Injection has been approved by US FDA